Demographics |
Age of diagnosis (years) | 48.1±17.1 | 50.5±16.5 | 0.552 |
Gender (males) | 61.5% | 62.1% | 0.942 |
FH of HCM/SCD | 34.6% | 32.0% | 0.747 |
NYHA functional class III or IV | 7.7% | 7.8% | 0.987 |
Patients on treatment | 55.8% | 46.6% | 0.281 |
B-blockers | 28.8% | 39.1% | 0.445 |
Calcium antagonists | 26.9% | 12.6% | 0.026 |
Amiodarone | 7.7% | 1.9% | 0.080 |
Diuretics | 13.5% | 9.7% | 0.480 |
Disopyramide | 3.8% | 9.7% | 0.197 |
Intracardiac defibrillator in situ | 5.8% | 5.8% | 0.989 |
Echocanliographic characteristics |
Ao (mm) | 31.3±3.7 | 33.2±5.8 | 0.123 |
LA (mm) | 40.9±7.3 | 39.9±7.3 | 0.593 |
LVED (mm) | 44.0±6.1 | 44.4±6.1 | 0.787 |
mLVWTd (mm) | 17.3±4.9 | 18.8±4.1 | 0.069 |
LV mass (g) | 279.6±106.5 | 287.6±112.7 | 0.767 |
FS (%) | 40.4±9.1 | 39.8±8.3 | 0.641 |
E wave (m/s) | 0.70±0.18 | 0.74±0.20 | 0.443 |
A wave (m/s) | 0.67±0.18 | 0.66±0.27 | 0.851 |
E/A | 1.11±0.44 | 1.22±0.58 | 0.422 |
SAM | 23.1% | 37.9% | 0.064 |
LVOT gradient = 30 mm Hg | 23.1% | 34.0% | 0.163 |
LVH pattern |
ASH | 25% | 57.3% | 0.004 |
Concentric | 44.2% | 30.1% |
Apical | 28.8% | 11.7% |
No hypertrophy | 1.9% | 1.0% |
Echocanliographic characteristics |
LVH (Sokolow & Lyon) | 53.8% | 35.9% | 0.033 |
Left atrial enlargement | 44.2% | 49.5% | 0.534 |
Pathological Q waves | 9.6% | 23.3% | 0.039 |
Left axis deviation | 11.5% | 17.2% | 0.270 |
Inverted T-waves | 82.7% | 69.9% | 0.086 |
T-wave inversions in V1–V4 | 3.8% | 3.9% | 0.991 |
T-wave inversions in inferior leads | 1.9% | 5.8% | 0.269 |
T-wave inversions in lateral leads | 76.9% | 60.2% | 0.038 |
Deep T-wave inversions | 69.2% | 51.5% | 0.035 |
ST-segment elevation | 9.6% | 9.7% | 0.985 |
ST-segment depression | 50% | 35.0% | 0.071 |